You can view the list of prize winners at the WMS-14 Geneva congress, an annual tradition.
WMS 2009 Young Investigator Prizes | ||||||||
Presentation | Page | Author | Title | |||||
Lea Rose Prize: | ||||||||
GP.9.08 | 33 | Emily Oates | Insights into the pathological basis of autosomal dominant distal spinal muscular atrophy from a large Australian family | |||||
President's Prize: Young Myologist of the Year | ||||||||
EM.P.5.05 GP.12.05 |
44 46 |
James Dowling | Zebrafish models of collagen VI myopathies Myotubularins and the pathogenesis of centronuclear myopathies |
|||||
President's Prize: First Time Presenter | ||||||||
EM.O.1 | 34 | Kinga Gawlik | E3 domain of laminin α1 chain that binds to dystroglycan is not essential for survival and muscle regeneration in laminin α1 chain mediated correction of laminin α2 chain deficiency | |||||
Elsevier Prizes (4) | ||||||||
G.O.3 | 18 | Jessica de Greef | Contraction-dependent (FSHD1) and independent (FSHD2) epigenetic changes of D4Z4 unify FSHD | |||||
T.O.1 | 52 | May Christine Malicdan | Sialic acid metabolites preclude the development of myopathic phenotype in the DMRV/hIBM mouse model | |||||
G.O.4 | 18 | Kate Quinlan | a-Actinin-3 regulates muscle glycogen phosphorylase: a potential mechanism for the metabolic consequences of the common human null allele of ACTN3 | |||||
TP.4.10 | 39 | Valerie Robin | Towards a better understanding of truncated dystrophin instability | |||||
Subscription Prizes | ||||||||
1 | TP.2.07 | 29 | Alison Blain | Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism | ||||
2 | MP.5.08 | 43 | Johann Böhm | In vivo imaging of muscle fibres under normal and pathological conditions | ||||
3 | GP.13.02 | 46 | Matteo Bovolenta | Non-coding RNAs within the DMD gene | ||||
4 | EM.P.3.02 | 27 | Virginie Carmignac | Intracellular signalling pathway alterations in laminin α2 chain deficient skeletal muscle and brain | ||||
5 | GP.6.05 | 30 | Yen-hui Chiu | Attenuated muscle regeneration is a key factor in dysferlinopathy | ||||
6 | GP.12.11 | 46 | Belinda Cowling | In vivo manipulation of skeletal muscle to characterize the mechanisms underlying centronuclear myopathies | ||||
7 | GP.14.11 | 48 | Michela De Bellis | Newly synthesized mexiletine and tocainide analogues are potent use-dependent blockers of skeletal muscle sodium channels: potential implication for the antimyotonic activity | ||||
8 | MP.4.07 | 36 | Claudia Escher | Reverse protein arrays for efficient protein diagnosis of muscular dystrophies in less that 10mg muscle tissue | ||||
9 | EM.P.2.11 | 21 | Poliana Martins Machado | Fukutin-related protein expression in murine dystrophic models carrying single and double mutations for dystrophin and LARGE | ||||
10 | EM.P.1.04 | 19 | Sarina Meinen | Treatment approaches in laminin-α2-deficient congenital muscular dystrophy (MDC1A) | ||||
11 | TP.1.08 | 28 | Chalemchai Mitrpant | The use of antisense oligomer for splice switching in spinal muscular atrophy fibroblasts | ||||
12 | TP.1.09 | 28 | Capucine Trollet | Oculopharyngeal muscular dystrophy (OPMD) : physiopathological mechanisms and gene therapy approaches | ||||
13 | TP.5.04 | 39 | Maaike van Putten | Effect of a mild exercise regime on disease parameters in the mdx mouse model | ||||
14 | MP.1.06 | 18 | Tracey Willis | An international registry for FKRP (Fukutin-Related Protein) patients - the first international registry |